Blog

Certain drugs such as Boldenone, Oxymetholone, Testosterone and Erythropoietin (EPO) have the ability to improve erythropoiesis process and increase hemoglobin, hematocrit. Androgenic-anabolic steroids (AAS) in general stimulate EPO production from renal cortex, production of red cells from bone marrow and

Indications for therapeutic administration of androgenic anabolic steroids (AAS) are: hypogonadism, osteopenia-fractures, muscle wasting-cachexia syndrome associated with HIV infection (AIDS), burn injury, severe aplastic anemia and other myelodysplastic syndromes, the congenital angioedema and sarcopenia in the elderly. AAS have beneficial

STEROIDS WITH THE HIGHEST ANDROGENIC INDEX 1) methyltrienolone (6000) 2) fluoxymesterone (800) 3) trenbolone (500) STEROIDS WITH THE LOWEST ANDROGENIC INDEX 1) oxandrolone (24) 2) stanozolol (30) 3) nandrolone (37) 4) oxymetholone (45) 5) boldenone (50) 6) methenolone (57) SLOW

Nandrolone is an anabolic steroid more anabolic than methenolone, which promotes strength and lean muscle mass gain. The drug has a positive effect in joints and their lubrication. It stimulates aldosterone from the kidneys, leading to sodium retention and edema. Moreover, it enhances

Boldenone (Equipose) is a veterinary injectable anabolic steroid, derivative of testosterone. It exhibits strong androgenic and anabolic properties. It is moderately aromatised to beta estradiol (E2) compared to nandrolone, therefore leading to less water retention. However estrogenic side effects such

Trenbolone is a 19-nortestosterone derivative with a chemical structure resembling nandrolone. It is of high androgenicity and anabolic activity (about five times higher that testosterone), ideal during precontest preparation and dieting. Trenbolone has a positive effect on fat burning and catabolism

Mesterolone is a synthetic form of diydroxytestosterone (DHT). It has a mild anti-estrogenic and androgenic action. Mesterolone improves body composition, through beta oxidation of fatty acids. It improves dramatically libido, since it binds strongly with the sex hormone binding globulin (SHBG).

Drostanolone (Masterone) is medically prescribed as an  anti-estrogenic therapy for the treatment of advanced inoperable breast cancer in postmenopausal women. It was originally manufactured under pharmaceutical production by Lilly/Syntex during the 1970s. The drug is an injectable AAS derived from dihydrotestosterone (DHT). It